Investor Presentation for the Quarter Ended 30th September 2026

AHCL/SE/37/2026-27 November 3, 2026 The National Stock Exchange of India BSE Limited Limited Department of Corporate “Exchange Plaza”, C-1, Block G Services 1st Floor, Bandra-Kurla Complex, Bandra P.J. Towers, Dalal Street, (E) Mumbai 400 051 Mumbai 400 001 ISIN: INE098F01031 Symbol: AMRUTANJAN Scrip Code: 590006 Dear Sir/ Madam, Sub: Investor Presentation for the quarter ended September 30, 2026 Pursuant to Regulation 30 read with Para A of part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we hereby enclose the investor presentation for the quarter and half year ended 30th September 2026. Request you to take the above on record. For Amrutanjan Health Care Limited (GAGAN PREET SINGH) General Manager - Legal Company Secretary & Compliance Officer Amrutanjan Health Care Limited I 03, (Old No. 42-45), Luz Church Road, E-mail :customercare@amrutanjan.com Mylapore, Chennai - 600 004 WebSite : www. amrutanjan.com Tamil Nadu, India. Toll Free No.: I • 800 - 425 - 4545 Tel :+91-44 - 2499 4465 CIN-L24231TN1936PLC000017 +91-44 • 2466 9000 Fax :+91-44 - 2499 4585 Amrutanjan Health Care Limited Focused Execution Stronger Momentum INVESTOR PRESENTATION Quarter & Half Year Ended 30th September 2026 Date: 3rd November 2026 Contents a. Business Update 1. Segment Performance 2. Operations b. Financials 1. Q2 FY27 Performance 2. H1 FY27 Performance c. Management Commentary Investor Presentation | Quarter and Half Year Ended 30th September 2026 Business Update Investor Presentation | Quarter and Half Year Ended 30th September 2026 Sustainable growth in our core business while expanding into strategic categories H1 FY26-27 Q2 FY26-27 Outlets ₹249.3 Cr 13.0% ₹141.6 Cr 15.3% 1.1 Mn* Net Sales Growth YOY Net Sales Growth YOY *Outlets covered as per IQVIA MAT Sep26 Investor Presentation | Quarter and Half Year Ended 30th September 2026 Balanced growth across our portfolio underscores structural resilience of our brands Pain Management Women’s Hygiene Congestion Management Rehydration ₹6.2 Cr H1 ₹141.9 Cr ₹80.3 Cr ₹12.3 Cr 6.1% Growth over LY 20.5% Growth over LY 0.5% Growth over LY 1% Growth over LY ₹87.6 Cr ₹43.4 Cr ₹3.9 Cr ₹3.5Cr 13.5% Growth over LY 20.4% Growth over LY -3.7% Growth over LY -21.4% Growth over LY Pain Management Women’s Hygiene Congestion Management Rehydration [Product 4 | month] Investor Presentation | Quarter and Half Year Ended 30th September 2026 Head and Body Roll-On driving growth for Pain Management Head Roll On 27% Body Roll On 19% Large Packs 13% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Our strategic focus on increasing market penetration continues to drive consistent, high growth in the Women’s Hygiene category Regular Pads 7% Dry XL Pads 43% Value Packs 32% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Congestion Management is mirroring broader FMCG health care trends Cough Drops Cold Rub Large Packs Investor Presentation | Quarter and Half Year Ended 30th September 2026 Electro+ ORS addressing rehydration needs of new consumer segments ORS Orange 6.2X ORS Apple 94% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Strategic Pillars – Update in H1 FY26-27 Strategic Pillars Update Portfolio: Strengthen Power brands and expand into Launched new variants in Pain Management like Cool Balm, Hero Balm adjacencies Continued investments across all media platforms for Brand Building: Bring in new consumers all power brands Reach and Availability: Expand into West and North, Focused approach in expanding to new towns, villages Grocers and Quick Commerce and placement of relevant SKUs across channel types Operational Excellence: Improve operating leverage by Creation of infrastructure and working towards enhancing process capabilities across organization automation of processes in all possible areas Work on succession planning, career development, People and Skills- Retain. Grow. Attract competency assessment Investor Presentation | Quarter and Half Year Ended 30th September 2026 Addressing needs of new consumer segments with Cool Balm and driving penetration through Hero Balm INITIATIVES | New Product Launch Cool Balm No Burning No Irritation Cooling Sensation Balm Hero Balm Small pack to increase penetration Initial acceptance among the retailers and consumers is encouraging for both the products Investor Presentation | Quarter and Half Year Ended 30th September 2026 Induce trials, create awareness and consideration for existing and new products in the pain management category across 11 States, 32 towns, 4+ Lakhs consumers INITIATIVES | Marketing Investor Presentation | Quarter and Half Year Ended 30th September 2026 Associating with high impact properties to drive awareness and consideration for brand Amrutanjan INITIATIVES | Marketing Sponsor Big Boss Kannada KBC Association Investor Presentation | Quarter and Half Year Ended 30th September 2026 Drove awareness for brand Relief through investments in Digital and in shop activities INITIATIVES | Marketing Digital Media Campaign Investor Presentation | Quarter and Half Year Ended 30th September 2026 Educating school girls about menstrual hygiene across 5 states reaching 2.5 + lakh students INITIATIVES | Marketing Investor Presentation | Quarter and Half Year Ended 30th September 2026 Continued high investments in TV and Digital media coupled with on-ground activities for brand Comfy INITIATIVES | Marketing Investor Presentation | Quarter and Half Year Ended 30th September 2026 Enerlyte restores electrolytes lost during daily work, marathons, and sporting events, impacting over 1 lakh consumers INITIATIVES | Marketing Investor Presentation | Quarter and Half Year Ended 30th September 2026 Educate consumers on the need for electrolytes through Digital and on ground initiatives INITIATIVES | Marketing Digital Media Campaign Investor Presentation | Quarter and Half Year Ended 30th September 2026 Sales and Distribution Initiatives in H1 FY26-27 Sales Infrastructure (Stockiest Network) Increased by 7% Productive Calls Increased by 9% Total Outlets Coverage Increased by 19% Total Lines Sold Increased by 19% Effective Outlet Coverage Increased by 5% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Information Technology: Digitization for Efficiency Improvement SAP initiatives SAP implementation for new Comfy plant completed Sales Digitization Distributor Management System (DMS), SAP Payroll Implementation in progress Investor Presentation | Quarter and Half Year Ended 30th September 2026 Human Resource: Enhancing Capabilities and Competence New Labour Code & PF Notification Salary restructuring and PF changes completed as per new wage code and PF notification Training Sales /Product training for all our field and Mid level managerial employees Competence Assessments Competency Assessments and career development activities initiated Investor Presentation | Quarter and Half Year Ended 30th September 2026 Financials Investor Presentation | Quarter and Half Year Ended 30th September 2026 Financials – Q2 FY27 (Rs. in Crores) Net Sales 135.18 117.70 Profit After Tax 17.28 13.96 Q2 FY27 Q2 FY26 Growth: 14.85% Profit Before Tax Q2 FY27 Q2 FY26 23.10 19.21 Growth: 23.78% Q2 FY27 Q2 FY26 Growth: 20.25% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Segment results – Q2 FY27 (Rs. in Crores) Net Sales – Women’s Hygiene & Personal care 40.48 Net Sales - OTC 32.78 90.94 80.02 Q2 FY27 Q2 FY26 Growth: 23.49% Q2 FY27 Q2 FY26 Net Sales – Women’s Hygiene Growth: 13.65% 39.72 32.78 Q2 FY27 Q2 FY26 Growth: 21.17% Investor Presentation | Quarter and Half Year Ended 30th September 2026 Segment results – Q2 FY27 (Rs. in Crores) Net Sales - Hydration drinks Net Sales - Beverages (Included in Beverages) 4.29 3.72 3.03 2.86 Q2 FY27 Q2 FY26 Q2 FY27 Q2 FY26 Investor Presentation | Quarter and Half Year Ended 30th September 2026 Financ [Showing first 8,000 characters — download PDF for full document]